PortfoliosLab logoPortfoliosLab logo
XMLH.DE vs. GN0M.DE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

XMLH.DE vs. GN0M.DE - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in L&G Healthcare Technology & Innovation UCITS ETF USD Acc (XMLH.DE) and Global X Genomics & Biotechnology UCITS ETF (GN0M.DE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, XMLH.DE achieves a 8.53% return, which is significantly lower than GN0M.DE's 24.33% return.


XMLH.DE

1D
-0.63%
1M
9.04%
6M
3.67%
YTD
8.53%
1Y
37.82%
3Y*
7.32%
5Y*
-2.65%
10Y*

GN0M.DE

1D
0.00%
1M
12.61%
6M
17.15%
YTD
24.33%
1Y
64.71%
3Y*
4.19%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

XMLH.DE vs. GN0M.DE - Yearly Performance Comparison


2026 (YTD)20252024202320222021
XMLH.DE
L&G Healthcare Technology & Innovation UCITS ETF USD Acc
8.53%11.69%8.01%-4.50%-29.19%-5.48%
GN0M.DE
Global X Genomics & Biotechnology UCITS ETF
24.33%5.67%-12.40%-9.04%-32.50%-7.53%

Correlation

The correlation between XMLH.DE and GN0M.DE is 0.78, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.78

Correlation (3Y)
Calculated over the trailing 3-year period

0.79

Correlation (All Time)
Calculated using the full available price history since Nov 11, 2021

0.83

The correlation between XMLH.DE and GN0M.DE has been stable across timeframes, ranging from 0.78 to 0.83 - a consistent structural relationship.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

XMLH.DE vs. GN0M.DE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

XMLH.DE
XMLH.DE Risk / Return Rank: 6767
Overall Rank
XMLH.DE Sharpe Ratio Rank: 7676
Sharpe Ratio Rank
XMLH.DE Sortino Ratio Rank: 7979
Sortino Ratio Rank
XMLH.DE Omega Ratio Rank: 6969
Omega Ratio Rank
XMLH.DE Calmar Ratio Rank: 6565
Calmar Ratio Rank
XMLH.DE Martin Ratio Rank: 4444
Martin Ratio Rank

GN0M.DE
GN0M.DE Risk / Return Rank: 8181
Overall Rank
GN0M.DE Sharpe Ratio Rank: 8888
Sharpe Ratio Rank
GN0M.DE Sortino Ratio Rank: 8686
Sortino Ratio Rank
GN0M.DE Omega Ratio Rank: 7878
Omega Ratio Rank
GN0M.DE Calmar Ratio Rank: 8686
Calmar Ratio Rank
GN0M.DE Martin Ratio Rank: 6868
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

XMLH.DE vs. GN0M.DE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for L&G Healthcare Technology & Innovation UCITS ETF USD Acc (XMLH.DE) and Global X Genomics & Biotechnology UCITS ETF (GN0M.DE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


XMLH.DEGN0M.DEDifference
Sharpe ratioReturn per unit of total volatility

-0.33

Sortino ratioReturn per unit of downside risk

-0.30

Omega ratioGain probability vs. loss probability

1.33

1.37

-0.04

Calmar ratioReturn relative to maximum drawdown

2.64

3.90

-1.26

Martin ratioReturn relative to average drawdown

5.92

9.85

-3.93

XMLH.DE vs. GN0M.DE - Sharpe Ratio Comparison

The current XMLH.DE Sharpe Ratio is 1.96, which is comparable to the GN0M.DE Sharpe Ratio of 2.29. The chart below compares the historical Sharpe Ratios of XMLH.DE and GN0M.DE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

XMLH.DE vs. GN0M.DE - Drawdown Comparison

The maximum XMLH.DE drawdown since its inception was -51.48%, smaller than the maximum GN0M.DE drawdown of -67.19%. Use the drawdown chart below to compare losses from any high point for XMLH.DE and GN0M.DE.


Loading charts...

Drawdown Indicators


XMLH.DEGN0M.DEDifference

Max Drawdown

Largest peak-to-trough decline

-51.48%

-67.19%

+15.71%

Max Drawdown (1Y)

Largest decline over 1 year

-15.46%

-16.68%

+1.22%

Max Drawdown (3Y)

Largest decline over 3 years

-28.40%

-45.68%

+17.28%

Max Drawdown (5Y)

Largest decline over 5 years

-50.58%

Current Drawdown

Current decline from peak

-21.16%

-35.12%

+13.96%

Average Drawdown

Average peak-to-trough decline

-25.17%

-42.95%

+17.78%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.91%

6.59%

+0.32%

Volatility

XMLH.DE vs. GN0M.DE - Volatility Comparison

The current volatility for L&G Healthcare Technology & Innovation UCITS ETF USD Acc (XMLH.DE) is 6.98%, while Global X Genomics & Biotechnology UCITS ETF (GN0M.DE) has a volatility of 8.70%. This indicates that XMLH.DE experiences smaller price fluctuations and is considered to be less risky than GN0M.DE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


XMLH.DEGN0M.DEDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.98%

8.70%

-1.72%

Volatility (6M)

Calculated over the trailing 6-month period

16.00%

20.26%

-4.26%

Volatility (1Y)

Calculated over the trailing 1-year period

21.03%

28.51%

-7.48%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

22.53%

31.42%

-8.89%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

23.79%

31.42%

-7.63%

XMLH.DE vs. GN0M.DE - Expense Ratio Comparison

XMLH.DE has a 0.49% expense ratio, which is lower than GN0M.DE's 0.50% expense ratio.


Dividends

XMLH.DE vs. GN0M.DE - Dividend Comparison

Neither XMLH.DE nor GN0M.DE has paid dividends to shareholders.


Tickers have no history of dividend payments

Frequently Asked Questions


XMLH.DE and GN0M.DE have a correlation of 0.78, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, XMLH.DE is cheaper at 0.49% per year. The better choice depends on whether you care most about return, fees, risk, or income.

XMLH.DE is cheaper with a 0.49% expense ratio, compared with 0.50% for GN0M.DE.

XMLH.DE tracks ROBO Global Healthcare Technology and Innovation Index, while GN0M.DE tracks Solactive Genomics. They also come from different issuers: L&G and Global X. Their fees differ too: 0.49% for XMLH.DE and 0.50% for GN0M.DE.

Portfolio Optimizer

Find the right allocation for XMLH.DE and GN0M.DE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer